Colomer Bosch, Ramon ramon.colomer@uam.es
Actividades
- Artículos 257
- Libros 4
- Capítulos de libro 3
- Congresos 91
- Documentos de trabajo 1
- Informes técnicos 4
- Proyectos de investigación 1
- Tesis dirigidas 9
- Patentes o licencias de software 0
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer
- Zagorac, Ivana
- Fernandez-Gaitero, Sara
- Penning, Renske
- Post, Harm
- Bueno, Maria J.
- Mouron, Silvana
- Manso, Luis
- Morente, Manuel M.
- Alonso, Soledad
- Serra, Violeta
- Munoz, Javier
- Gomez-Lopez, Gonzalo
- Francisco Lopez-Acosta, Jose
- Jimenez-Renard, Veronica
- Gris-Oliver, Albert
- Al-Shahrour, Fatima
- Pineiro-Yanez, Elena
- Luis Montoya-Suarez, Jose
- Apala, Juan V.
- Moreno-Torres, Amalia
- Colomer, Ramon
- Dopazo, Ana
- Heck, Albert J. R.
- Altelaar, Maarten
- Quintela-Fandino, Miguel;
Nature Communications - 1/12/2018
10.1038/s41467-018-05742-z Ver en origen
- ISSN 20411723
Skeletal muscle and solitary bone metastases from malignant melanoma: multimodality imaging and oncological outcome
- Gómez-León, N.
- Pacheco-Barcia, V.
- Ballesteros, A.I.
- Fraga, J.
- Colomer, R.
- Friera, A.
Melanoma Research (p. 562-570) - 1/12/2018
Editor: Lippincott Williams and Wilkins
10.1097/cmr.0000000000000466 Ver en origen
- ISSN 09608931
- ISSN/ISBN 1473-5636
Real-world treatment in patients with HER2+metastatic breast cancer
- Colomer, R.
- Hall, P.
- Szkultecka-Debek, M.
- Bondi, R. C.
- Flinois, A.
- Auziere, S.
- Le Cleac'h, J. Y.;
Breast Cancer Research And Treatment (p. 197-205) - 1/2/2018
10.1007/s10549-017-4567-z Ver en origen
- ISSN 01676806
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study
- Swain, S. M.
- Ewer, M. S.
- Viale, G.
- Delaloge, S.
- Ferrero, J-M
- Verrill, M.
- Colomer, R.
- Vieira, C.
- Werner, T. L.
- Douthwaite, H.
- Bradley, D.
- Waldron-Lynch, M.
- Kiermaier, A.
- Eng-Wong, J.
- Dang, C.;BERENICE Study Grp
Annals Of Oncology (p. 646-653) - 1/3/2018
10.1093/annonc/mdx773 Ver en origen
- ISSN 09237534
Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology
- Palacios Calvo J
- Albanell J
- Rojo F
- Ciruelos E
- Aranda-López I
- Cortés J
- García-Caballero T
- Martín M
- López-García M
- Colomer R
Revista Espanola De Patologia (p. 97-109) - 1/4/2018
10.1016/j.patol.2017.12.002 Ver en origen
- ISSN 1988561X
Predictors of unknown cancer in patients with ischemic stroke
- Quintas, S.
- Rogado, J.
- Gullón, P.
- Pacheco-Barcia, V.
- Dotor García-Soto, J.
- Reig-Roselló, G.
- Mondéjar, R.
- Colomer, R.
- Vivancos, J.
Journal Of Neuro-Oncology (p. 551-557) - 1/5/2018
Editor: Springer New York LLC
10.1007/s11060-017-2741-0 Ver en origen
- ISSN 0167594X
- ISSN/ISBN 1573-7373
Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology (vol 20, pg 815, 2018)
- Colomer, R.
- Aranda-Lopez, I.
- Albanell, J.
- Garcia-Caballero, T.
- Ciruelos, E.
- Lopez-Garcia, M. A.
- Cortes, J.
- Rojo, F.
- Martin, M.
- Palacios-Calvo, J.;
Clinical & Translational Oncology (p. 1093-1095) - 1/8/2018
10.1007/s12094-018-1909-1 Ver en origen
- ISSN 1699048X
Nivolumab-induced thyroid dysfunction in patients with lung cancer
- Ramos Leví, Ana María
- Rogado, J
- Sánchez Torres, José Miguel
- Colomer Bosch, Ramón
- Marazuela Azpiroz, Mónica
Endocrinologia Diabetes Y Nutricion (p. 26-34) - 1/1/2019
10.1016/j.endinu.2018.05.005 Ver en origen
- ISSN 25300180
Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval
- Ciruelos E, Alba E, López R, Lluch A, Martín M, Arroyo I, Navarro B, Carcedo D, Colomer R, Albanell J
Oncotarget (p. 4321-4332) - 1/1/2019
- ISSN 19492553
- iMarina
Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells
- Bueno, Maria J.
- Jimenez-Renard, Veronica
- Samino, Sara
- Capellades, Jordi
- Junza, Alejandra
- Luz Lopez-Rodriguez, Maria
- Garcia-Carceles, Javier
- Lopez-Fabuel, Irene
- Bolanos, Juan P.
- Chandel, Navdeep S.
- Yanes, Oscar
- Colomer, Ramon
- Quintela-Fandino, Miguel;
Nature Communications (p. 1-18) - 1/12/2019
10.1038/s41467-019-13028-1 Ver en origen
- ISSN 20411723
- iMarina
- iMarina
Tratado de oncología
- Hernán Cortés-Funes
- Ramón Colomer Bosch
- Emilio Alba Conejo
1/1/2009
- ISBN 9788492620166
- iMarina
Adding pertuzumab in neoadjuvant treatment of patients with HER2 (+) breast cancer in Spain: A cost offsets study
- J Albanell
- E Ciruelos
- R Colomer
- J De la Haba
- M Martin
- De Salas-Cansado
- B Munoz-Molina
- C Tournier
- P Thuresson
- W Schleich
1/1/2015
- iMarina
Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
- J Rogado
- MD Fenor De La Maza
- V Pacheco-Barcia
- JM Serra
- P Toquero
- B Vera
- A Ballesteros
- R Mondejar
- O Donnay
- B Obispo
- R Colomer
- JM Sanchez-Torres
1/1/2017
- iMarina
Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …
- Chau Dang
- Michael S Ewer
- Suzette Delaloge
- Jean-Marc Ferrero
- Mark Verrill
- Ramon Colomer
- Claudia Vieira
- Luis de la Cruz Merino
- Jennifer Lucas
- Theresa L Werner
- Hannah Douthwaite
- Denise Bradley
- Maeve Waldron-Lynch
- Jennifer Eng-Wong
- Sandra M Swain
1/1/2018
- iMarina
Tratamiento hormonal del cáncer
- Ramón Colomer Bosch
- M L Amador
- J González Cortijo
- MV Tornamira
Oncología En Atención Primaria / Coord. Por Vicente Valentín Maganto - 1/1/2003
- iMarina
Fatty acid metabolism in cancer cell survival: A new anti-cancer target
- Porta, Rut
- Colomer, Ramon
- Puig, Teresa;
Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011
- iMarina
CA 15.3 - A NEW MARKER FOR BREAST-CANCER (BC) PRELIMINARY-RESULTS
- SOLE, LA
- COLOMER, R
- NAVARRO, M
- ENCABO, G
- RUIBAL, A;
Anticancer Research (p. 601-602) - 1/1/1985
- ISSN 02507005
- iMarina
USEFULNESS OF CA-15.3 SERIC LEVELS IN CLINICAL-PRACTICE
- RUIBAL, A
- COLOMER, R
- ROSELL, M
- GRIS, JM;
Tumour Biology (p. 315-315) - 1/1/1986
- ISSN 02895447
- iMarina
Prognosis factors in low grade non Hodgkin's lymphoma (NHL). Results of an analysis performed in 124 patients homogeneously treated.
- Arranz, R
- Llamas, P
- Blas, C
- Colomer, R
- Sobrino, P
- Nicolas, C
- Alfonso, PG
- Zamora, P
- Lopez, J
- Perez, G
- Garcialarana, J
- Lozano, M
- Fernandezranada, JM
Blood (p. 3868-3868) - 1/1/1997
- ISSN 00064971
- iMarina
A decade of clinical investigation in elderly patients with non-Hodgkin's lymphoma: Results as reported in the literature
- Gomez, H
- Colomer, R
- Casttellanos, D
- CortesFunes, H;
European Journal Of Cancer (p. 1205-1205) - 1/1/1997
- ISSN 09598049
- iMarina
Paclitaxel plus doxorubicin in metastatic breast cancer: Preliminary analysis of cardiotoxicity
- Miguel Martin
- Ana Lluch
- Belen Ojeda
- A Barnabas
- Ramon Colomer
- Bartomeu Massuti
- Dolores Benito
Seminars In Oncology (p. S17-26) - 8/12/1997
- ISSN 00937754
- iMarina
Study of escalating doses of paclitaxel plus cisplatin in patients with inoperable head and neck cancer
- Hitt, R
- Hornedo, J
- Colomer, R
- Hidalgo, M
- Brandariz, A
- Pena, M
- Vicent, JA
- CortesFunes, H;
Seminars In Oncology (p. S2-58) - 22/3/1997
- ISSN 00937754
- iMarina
Circulating erbB-2 and resistance to chemotherapy in advanced breast cancer.
- R Colomer
- S Montero
- A Liuch
- B Ojeda
- A Barnadas
- A Casado
- B Massuti
- B Lloveras
- H Cortes-Funes
Clinical Cancer Research (p. 3772S-3772S) - 1/1/1999
- ISSN 15573265
- iMarina
Kinetic analysis of a combination of gemcitabine with vinorelbine in human breast adenocarcinoma MCF-7 cells in vitro
- Barbacid, MM
- Montero, S
- Menendez, JA
- Cortes-Funes, H
- Colomer, R;
European Journal Of Cancer (p. S14-S14) - 1/1/1999
- ISSN 09598049
- iMarina
Effect of oleic acid on the chemosensitivity of breast cancer cells
- Menendez, JA
- Barbacid, MM
- Montero, S
- Cortes-Funes, H
- Colomer, R;
European Journal Of Cancer (p. S14-S14) - 1/1/1999
- ISSN 09598049
- iMarina
[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]
- Sanchez-Munoz, A
- Gravalos Castro, C
- Colomer Bosch, R
- Garcia Velasco, A
- Garcia, J P
- Cortes-Funes, H
Revista Clinica Espanola (p. 597-598) - 1/1/2003
- ISSN 15781860
- iMarina
Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.
- Hitt, R
- Paz-Ares, L
- Hidalgo, M
- Colomer, R
- Brandariz, A
- Pena, M
- Alvarez-Vicent, J
- Hornedo, J
- Cortes-Funes, H;
Seminars In Oncology (p. S19-20) - 1/12/1997
- ISSN 00937754
- iMarina
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization
- Arranz, R.
- García-Alfonso, P.
- Sobrino, P.
- Zamora, P.
- Carrión, R.
- García-Laraña, J.
- Pérez, G.
- López, J.
- Lavilla, E.
- Lozano, M.
- Rayón, C.
- Colomer, R.
- González Barón, M.
- Flores, E.
- Pérez-Manga, G.
- Fernández-Rañada, J.M.
Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998
Editor: American Society of Clinical Oncology
10.1200/jco.1998.16.4.1538 Ver en origen
- ISSN 0732183X
- ISSN/ISBN 0732-183X
- Dialnet
- iMarina
A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer
- Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R
Clinical Breast Cancer (p. 286-91) - 1/1/2003
10.3816/cbc.2003.n.034 Ver en origen
- ISSN 15268209
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
- Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators
Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020
- ISSN 0732183X
- iMarina
Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater
1/1/1996
- iMarina
Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez
1/1/2001
- iMarina
Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz
1/1/2002
- iMarina
Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo
1/1/2003
- iMarina
Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia
1/1/2004
- iMarina
Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín
1/1/2007
- iMarina
Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís
1/1/2016
- iMarina
El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Javier Abel Menéndez Menéndez (Director)
- Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo
1/1/2016
- iMarina
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Publons
-
Scopus Author ID
-
Dialnet id